Evidence Health
← Search another medicinePrintable summary →

Meclizine Hcl 25mg Chewable Tablets

Also sold as Meclizine HCL

From 1 official FDA drug label · RxNorm 995632

This comes from U.S. FDA labels. Brand names, strengths and advice can differ in your country; check with a local health professional. Set your country.

What it is used for

These are the uses the FDA has approved for this label. Using it for anything else is “off-label”: ask your prescriber why.

Uses For the prevention and treatment of nausea, vomiting or dizziness associated with motion sickness. For other uses consult your doctor

How to take it

Directions take dose one hour before travel starts tablets can be chewed or swallowed whole with water adults & children 12 years and over: take 1-2 tablets once daily children under 12 years: ask a doctor

Serious warnings and precautions

Warnings Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis trouble urinating due to an elarged prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product you may get drowsy avoid alcoholic drinks alcohol, sedatives and tranquilizers may increse drowsiness be careful when driving a moor vehicle or operating machinery

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Forms and strengths available

25 MG · Disintegrating Oral Tablet50 MG · Chewable Tablet12.5 MG · Oral Tablet25 MG · Chewable Tablet25 MG · Oral Tablet30 MG · Oral Tablet50 MG · Oral Tablet

From RxNorm. Which forms and strengths are actually stocked varies by pharmacy and country.

Reactions people have reported

diarrhoea 3haemoglobin decreased 3dizziness 2bronchitis 2abdominal pain 2ligament sprain 1endometriosis 1asthenia 1hypertension 1gastroenteritis 1

These are counts from 11 voluntary reports to the FDA. They show what has been reported — they are not how common a side effect is, and they do not prove the medicine caused it.

Recalls

Class II · Apr 1, 2026
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Reason: Failed tablet specifications.
Class II · Jun 15, 2022
Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15
Reason: cGMP deviations: Temperature abuse
Class I · Apr 6, 2022
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Reason: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Class III · Nov 20, 2019
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
Reason: Subpotent Drug
Class III · Nov 20, 2019
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,
Reason: Subpotent Drug
Class III · Nov 22, 2017
Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06
Reason: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

Research & studies

Recent higher-quality studies about Meclizine Hcl 25mg Chewable Tablets, from PubMed. We link to the source — titles only. This is not medical advice.

ReviewEfficacy and safety of tradipitant in motion sickness: a systematic review and meta-analysis.Acta neurologica Belgica · 2026 Aug 12ReviewPromising horizons in achondroplasia along with the development of new drugs.Endocrine journal · 2024 Jul 12ReviewImportance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting α-synuclein and neuroprotection in the treatment of Parkinson's disease.Revue neurologique · 2024 OctReviewUnderstanding flow chemistry for the production of active pharmaceutical ingredients.iScience · 2022 Mar 18Meta-AnalysisSystems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.Archives of biochemistry and biophysics · 2022 Jan 15Systematic ReviewDrugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.The Cochrane database of systematic reviews · 2020 Oct 19

Similar medicines

Meclizine Hcl 25mg Chewable Tablets belongs to the Piperazine derivatives class. Other medicines in it:

cetirizine

Questions to ask your doctor or pharmacist

Why you can trust this

Everything above comes from official FDA drug labels (openFDA), not written by us. Here are the exact labels used.

This information explains the official label. It cannot tell you whether this medicine is right or safe for you personally — only a qualified health professional who knows your history can do that. Do not start, stop, or change a medicine based on this page alone.